MedPath

Coagulation monitoring to prevent hemostatic complications in extra corporeal membrane oxygenation in kids.

Conditions
Any, requiring ECMO
Registration Number
NL-OMON28010
Lead Sponsor
ot applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Child (<18 years) on ECMO

Exclusion Criteria

> 24 hours on ECMO
No informed consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The first hemostatic complication in the first 14 days of ECMO therapy and the test results of conventional and viscoelastic coagulation tests.
Secondary Outcome Measures
NameTimeMethod
Incidence of hemostatic complications and the survival of children on ECMO with and with hemostatic complications.
© Copyright 2025. All Rights Reserved by MedPath